Showing results (871-880 of 897) with videos related to

Sort By:
Pageof 90
British Journal of Cancer|March 20, 2014
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapyT Hamada, Y Nakai, H Yasunaga, et al.
Nucleic Acids Research|January 11, 2000
HUNT: launch of a full-length cDNA database from the Helix Research InstituteH T Yudate, M Suwa, R Irie, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
British Journal of Pharmacology|November 30, 2011
Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activityM Biffen, H Matsui, S Edwards, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusionsCarol Ann Huff, Ephraim J Fuchs, B Douglas Smith, et al.
Leukemia Research|September 14, 2016
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studiesKelly J Norsworthy, Eunpi Cho, Jyoti Arora, et al.
Blood Advances|December 16, 2017
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamideYvette L Kasamon, Richard F Ambinder, Ephraim J Fuchs, et al.
Leukemia & Lymphoma|July 28, 2012
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemiaYvette L Kasamon, Robert A Brodsky, Michael J Borowitz, et al.
Leukemia Research|July 6, 2010
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSFB Douglas Smith, Richard J Jones, Eunpi Cho, et al.
Pageof 90